Eurofins Scientific SE Share Price
Stocks
ERF
FR0014000MR3
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 68.28 EUR | +1.88% |
|
+8.59% | +9.42% |
| 05/06 | Eurofins Scientific SE acquired High North Laboratories. | CI |
| 14/05 | Eurofins Scientific SE Develops And Offers New Solutions For Hantavirus Detection | CI |
| Market Cap | 1.19TCr 1.36TCr 1.1TCr 1.03TCr 1.93TCr 1,28200Cr 1.96TCr 13TCr 5.11TCr 63TCr 5.1TCr 4.99TCr 2,19600Cr | P/E 2026 * |
23.7x | P/E 2027 * | 18.2x |
|---|---|---|---|---|---|
| Enterprise Value | 1.54TCr 1.75TCr 1.42TCr 1.32TCr 2.48TCr 1,65200Cr 2.53TCr 17TCr 6.58TCr 81TCr 6.57TCr 6.43TCr 2,82900Cr | EV / Sales 2026 * |
2.02x | EV / Sales 2027 * | 1.86x |
| Free-Float |
58.35% | Yield 2026 * |
1.13% | Yield 2027 * | 1.32% |
Last Transcript: Eurofins Scientific SE
| 1 day | +1.88% | ||
| 1 week | +8.59% | ||
| Current month | +9.32% | ||
| 1 month | +7.97% | ||
| 3 months | +10.20% | ||
| 6 months | +9.88% | ||
| Current year | +9.42% |
| 1 week | 62.16 |  | 68.76 |
| 1 month | 60.76 | | 68.76 |
| Current year | 56.84 | | 74.32 |
| 1 year | 54.86 | | 74.32 |
| 3 years | 39.47 | | 74.32 |
| 5 years | 39.47 | | 127.68 |
| 10 years | 29.82 | | 127.68 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gilles Martin
CEO | Chief Executive Officer | 63 | 01/01/1987 |
Laurent Lebras
DFI | Director of Finance/CFO | - | 01/01/2015 |
Christian Wurst
PRN | Corporate Officer/Principal | 53 | 01/10/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Gilles Martin
CHM | Chairman | 63 | 01/01/1987 |
Yves-Loïc Martin
BRD | Director/Board Member | 60 | 01/01/2015 |
Valérie Hanote
BRD | Director/Board Member | 60 | 01/01/1990 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 27/04 | Buy | 700 | 0.0004% | |||
| 19/04 | Fiscal year | Chief Financial Officer | 6,000 | 0.0033% | ||
| 19/04 | Sell | Executive/Senior Manager | 500 | 0.0003% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.88% | +8.59% | +13.76% | +20.68% | 1.33TCr | |
| +1.67% | +9.28% | -5.05% | +1.40% | 4.54TCr | |
| +4.95% | +9.31% | +363.86% | +598.16% | 3.61TCr | |
| +0.44% | +11.12% | +17.47% | -12.91% | 3.1TCr | |
| -0.64% | +1.92% | +3.08% | +53.58% | 3.08TCr | |
| +0.23% | -0.29% | +13.24% | +21.10% | 2.46TCr | |
| +9.90% | +13.32% | - | - | 1.48TCr | |
| +1.40% | +12.99% | +67.11% | +132.76% | 1.46TCr | |
| +2.38% | +5.69% | +95.85% | +97.63% | 1.26TCr | |
| +1.76% | +10.25% | +10.31% | -28.88% | 1.21TCr | |
| Average | +2.40% | +7.08% | +64.40% | +98.17% | 2.35TCr | |
| Weighted average by Cap. | +2.11% | +6.95% | +74.18% | +120.22% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 759.99Cr 865.2Cr 700.21Cr 654.71Cr 1.23TCr 82TCr 1.25TCr 8.4TCr 3.25TCr 40TCr 3.25TCr 3.18TCr 1,39900Cr | 807.43Cr 919.2Cr 743.92Cr 695.58Cr 1.3TCr 87TCr 1.33TCr 8.93TCr 3.46TCr 43TCr 3.45TCr 3.38TCr 1,48600Cr |
| Net income | 52Cr 59Cr 48Cr 45Cr 83Cr 5.55TCr 85Cr 571.15Cr 221.23Cr 2.74TCr 220.89Cr 216.04Cr 9.51TCr | 68Cr 77Cr 62Cr 58Cr 109.25Cr 7.26TCr 111.25Cr 747.45Cr 289.51Cr 3.58TCr 289.07Cr 282.73Cr 12TCr |
| Net Debt | 344.2Cr 391.85Cr 317.13Cr 296.52Cr 556.13Cr 37TCr 566.34Cr 3.8TCr 1.47TCr 18TCr 1.47TCr 1.44TCr 63TCr | 308.46Cr 351.16Cr 284.2Cr 265.73Cr 498.38Cr 33TCr 507.53Cr 3.41TCr 1.32TCr 16TCr 1.32TCr 1.29TCr 57TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25/26/25 | €68.28 | +1.88% | 2,64,566 |
| 24/26/24 | €67.02 | +2.73% | 3,05,277 |
| 23/26/23 | €65.24 | +2.77% | 3,20,692 |
| 22/26/22 | €63.48 | +1.54% | 3,13,305 |
| 19/26/19 | €62.52 | -0.57% | 4,55,494 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ERF Stock
Select your edition
All financial news and data tailored to specific country editions
